Publication | Open Access

Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial

HypertensionRenal FunctionRenal DiseaseMedicineKidney FailurePharmacologyDiabetic Kidney DiseaseAldosterone Synthase InhibitionPharmacotherapyPhase 2Chronic Kidney DiseaseNephrologyKidney Research